Follow
Alison Holmes
Alison Holmes
Professor of Infectious Diseases
Verified email at imperial.ac.uk
Title
Cited by
Cited by
Year
Interventions to improve antibiotic prescribing practices for hospital inpatients
P Davey, E Brown, E Charani, L Fenelon, IM Gould, A Holmes, ...
Cochrane database of systematic reviews, 2013
27382013
Understanding the mechanisms and drivers of antimicrobial resistance
AH Holmes, LSP Moore, A Sundsfjord, M Steinbakk, S Regmi, A Karkey, ...
The Lancet 387 (10014), 176-187, 2016
23832016
Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing
TM Rawson, LSP Moore, N Zhu, N Ranganathan, K Skolimowska, ...
Clinical infectious diseases 71 (9), 2459-2468, 2020
17772020
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
10482021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
7922022
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
A Huttner, S Harbarth, J Carlet, S Cosgrove, H Goossens, A Holmes, ...
Antimicrobial resistance and infection control 2, 1-13, 2013
5622013
Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus
W Zingg, A Holmes, M Dettenkofer, T Goetting, F Secci, L Clack, ...
The Lancet Infectious Diseases 15 (2), 212-224, 2015
5402015
Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette”
E Charani, E Castro-Sánchez, N Sevdalis, Y Kyratsis, L Drumright, ...
Clinical Infectious Diseases 57 (2), 188-196, 2013
4612013
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ...
Cell reports 35 (13), 2021
4162021
Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London
J Zhou, JA Otter, JR Price, C Cimpeanu, DM Garcia, J Kinross, ...
medRxiv, 2020.05. 24.20110346, 2020
345*2020
COVID-19 and the potential long-term impact on antimicrobial resistance
TM Rawson, LSP Moore, E Castro-Sanchez, E Charani, F Davies, G Satta, ...
Journal of antimicrobial chemotherapy 75 (7), 1681-1684, 2020
3442020
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ...
The Lancet Public Health 6 (5), e335-e345, 2021
3362021
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications
N Peiffer-Smadja, TM Rawson, R Ahmad, A Buchard, P Georgiou, ...
Clinical Microbiology and Infection 26 (5), 584-595, 2020
3052020
Quantifying drivers of antibiotic resistance in humans: a systematic review
A Chatterjee, M Modarai, NR Naylor, SE Boyd, R Atun, J Barlow, ...
The Lancet Infectious Diseases 18 (12), e368-e378, 2018
3002018
Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review
E Charani, R Edwards, N Sevdalis, B Alexandrou, E Sibley, D Mullett, ...
Clinical Infectious Diseases 53 (7), 651-662, 2011
2762011
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?
A Holmes, J Govan, R Goldstein
Emerging infectious diseases 4 (2), 221, 1998
2681998
Health literacy and infectious diseases: why does it matter?
E Castro-Sánchez, PWS Chang, R Vila-Candel, AA Escobedo, ...
International Journal of Infectious Diseases 43, 103-110, 2016
2652016
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain
L Sun, RZ Jiang, S Steinbach, A Holmes, C Campanelli, J Forstner, ...
Nature medicine 1 (7), 661-666, 1995
2551995
Is health care getting safer?
C Vincent, P Aylin, BD Franklin, A Holmes, S Iskander, A Jacklin, ...
Bmj 337, 2008
2452008
Antimicrobial use, drug-resistant infections and COVID-19
TM Rawson, D Ming, R Ahmad, LSP Moore, AH Holmes
Nature Reviews Microbiology 18 (8), 409-410, 2020
2432020
The system can't perform the operation now. Try again later.
Articles 1–20